Assenagon Asset Management Portfolio holdings
AUM
$63B
1-Year Return
16.23%
This Quarter Return
+2.68%
1 Year Return
+16.23%
3 Year Return
+96.75%
5 Year Return
+146.12%
10 Year Return
–
AUM
$55.7B
AUM Growth
+$7.26B
(+15%)
Cap. Flow
+$6.83B
Cap. Flow
% of AUM
12.25%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
1,435
New
117
Increased
473
Reduced
672
Closed
150
Top Buys
| 1 |
Microsoft
MSFT
|
$1.93B |
| 2 |
Tesla
TSLA
|
$1.46B |
| 3 |
Texas Instruments
TXN
|
$813M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$553M |
| 5 |
ConocoPhillips
COP
|
$351M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.16B |
| 2 |
NVIDIA
NVDA
|
$531M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$401M |
| 4 |
Netflix
NFLX
|
$313M |
| 5 |
Meta Platforms (Facebook)
META
|
$309M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Consumer Discretionary | 17.39% |
| 3 | Financials | 11.38% |
| 4 | Healthcare | 11.2% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Qiagen
QGEN
$10.3B
| $731K | ﹤0.01% |
15,953
+4,107
| +35% | +$188K |
|
1127
CarParts.com
PRTS
$60.1M
| $729K | ﹤0.01% |
675,371
+399,901
| +145% | +$432K |
|
1128
Seagate
STX
$40B
| $728K | ﹤0.01% |
8,436
-344
| -4% | -$29.7K |
|
1129
CAE Inc
CAE
$8.53B
| $723K | ﹤0.01% |
28,496
-5,405
| -16% | -$137K |
|
1130
TrueCar
TRUE
$191M
| $706K | ﹤0.01% |
189,144
+20,544
| +12% | +$76.6K |
|
1131
Ovintiv
OVV
$10.6B
| $698K | ﹤0.01% |
17,224
-1,341,790
| -99% | -$54.3M |
|
1132
Westamerica Bancorp
WABC
$1.26B
| $694K | ﹤0.01% |
13,226
-116,750
| -90% | -$6.12M |
|
1133
Inogen
INGN
$219M
| $683K | ﹤0.01% |
74,452
-160,429
| -68% | -$1.47M |
|
1134
Potbelly
PBPB
$383M
| $676K | ﹤0.01% |
71,718
-36,862
| -34% | -$347K |
|
1135
Black Hills Corp
BKH
$4.35B
| $672K | ﹤0.01% |
11,491
-286,142
| -96% | -$16.7M |
|
1136
Spectrum Brands
SPB
$1.38B
| $669K | ﹤0.01% |
7,914
-10,904
| -58% | -$921K |
|
1137
Leidos
LDOS
$23B
| $665K | ﹤0.01% |
4,613
-367
| -7% | -$52.9K |
|
1138
PG&E
PCG
$33.2B
| $663K | ﹤0.01% |
32,876
+1,423
| +5% | +$28.7K |
|
1139
BridgeBio Pharma
BBIO
$10.2B
| $662K | ﹤0.01% |
24,134
| – | – |
|
|
SAGE
1140
DELISTED
Sage Therapeutics
SAGE
| $656K | ﹤0.01% |
120,723
-65,316
| -35% | -$355K |
|
1141
Conagra Brands
CAG
$9.23B
| $649K | ﹤0.01% |
23,380
-1,266,371
| -98% | -$35.1M |
|
1142
Mercer International
MERC
$216M
| $649K | ﹤0.01% |
+99,775
| New | +$649K |
|
1143
Yum China
YUMC
$16.5B
| $646K | ﹤0.01% |
13,409
-2,453
| -15% | -$118K |
|
1144
RB Global
RBA
$21.4B
| $639K | ﹤0.01% |
7,085
-3,056
| -30% | -$276K |
|
1145
Astronics
ATRO
$1.37B
| $634K | ﹤0.01% |
39,724
-9,768
| -20% | -$156K |
|
1146
Allegion
ALLE
$14.8B
| $631K | ﹤0.01% |
4,826
-99
| -2% | -$12.9K |
|
1147
Principal Financial Group
PFG
$17.8B
| $630K | ﹤0.01% |
8,137
+660
| +9% | +$51.1K |
|
1148
Moderna
MRNA
$9.78B
| $623K | ﹤0.01% |
14,978
+1,819
| +14% | +$75.6K |
|
1149
CytomX Therapeutics
CTMX
$376M
| $618K | ﹤0.01% |
599,850
-1,044,318
| -64% | -$1.08M |
|
1150
Fate Therapeutics
FATE
$116M
| $615K | ﹤0.01% |
372,507
-2,061,691
| -85% | -$3.4M |
|